Celldex Therapeutics Stock Quote CLDX - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

43.36

Bid

31.04

Ask

44.44

Volume

541,888

42.045 Day's Range 44.28

19.85 52 Week Range 57.20

Market Cap

2.874B

Previous Close

41.75

Open

42.16

Last Trade

44.43

Last Trade Time

Financial Volume

$ 23,507,938

VWAP

43.3815

Average Volume (3m)

695,147

Shares Outstanding

66,287,596

Dividend Yield

PE Ratio

-20.70

Earnings Per Share (EPS)

-2.13

Revenue

6.88M

Net Profit

-141.43M

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung c... Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527. Show more

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Website

www.celldex.com

Headquarters

Wilmington, Delaware, USA

Founded

Celldex Therapeutics Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker CLDX. The last closing price for Celldex Therapeutics was $41.75. Over the last year, Celldex Therapeutics shares have traded in a share price range of $ 19.85 to $ 57.20.

Celldex Therapeutics currently has 66,287,596 shares outstanding. The market capitalization of Celldex Therapeutics is $2.77 billion. Celldex Therapeutics has a price to earnings ratio (PE ratio) of -20.70.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	10.165	30.6220816388	33.195	45.15	32.8	625520	39.76862513	CS
4	7.48	20.8472686734	35.88	46.86	31.4	712761	37.92368121	CS
12	-2.74	-5.94360086768	46.1	47.5	31.4	695147	38.44386523	CS
26	15.7	56.7606652205	27.66	53.18	22.11	754464	36.9194852	CS
52	-11.4	-20.8181154127	54.76	57.2	19.85	618255	35.50764588	CS
156	40.88	1648.38709677	2.48	57.2	1.5	695913	26.43826398	CS
260	0	0	0	45.15	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NOVVUNova Vision Acquisition Corporation	$ 41.00 (207.35%)	17.4k
NOVVNova Vision Acquisition Corporation	$ 37.0001 (200.08%)	205.22k
SMXSMX Security Matters Public Company	$ 5.85 (138.78%)	50.1M
OMICSingular Genomics Systems Inc	$ 12.38 (119.12%)	2.87M
TILInstill Bio Inc	$ 84.75 (82.41%)	3.91M
GSIWGarden Stage Ltd	$ 2.9693 (-75.66%)	4.24M
UPCUniverse Pharmaceuticals Inc	$ 0.55 (-67.07%)	30.45M
VMARVision Marine Technologies Inc	$ 0.77 (-48.67%)	34.54M
PRLDPrelude Therapeutics Inc	$ 2.775 (-42.55%)	2.49M
CNEYCN Energy Group Inc	$ 0.4335 (-37.17%)	5.06M
NVDANVIDIA Corporation	$ 119.10 (-0.03%)	225.83M
XXII22nd Century Group Inc	$ 0.3447 (28.00%)	168.56M
IMRXImmuneering Corporation	$ 2.02 (41.26%)	131.85M
SQQQProShares UltraPro Short QQQ	$ 8.17 (-1.33%)	122.46M
MULNMullen Automotive Inc	$ 0.1328 (-20.48%)	119.52M